1. Department of Bioequivalence Coordination, National Health Surveillance Agency of Brazil (Anvisa), Brazil; Federal University of Pernambuco (Laboratory Immunopathology Keizo Asami – LIKA/UFPE).
2. Bioequivalence Coordination of General Management of Drugs, National Health Surveillance Agency (Anvisa), Brazil.